PALONOSETRON HYDROCHLORIDE

PALONOSETRON HYDROCHLORIDE was reported 5372 times

PALONOSETRON HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PHARYNGEAL DYSKINESIA 9 0.3103
1 HYPERTENSIVE CARDIOMEGALY 3 0.0938
2 TRIPLE NEGATIVE BREAST CANCER 55 0.0817
3 GASTROINTESTINAL DILATION PROCEDURE 3 0.0638
4 SUBCLAVIAN ARTERY OCCLUSION 6 0.0594
5 BILIARY ABSCESS 2 0.0571
6 ATHEROSCLEROTIC PLAQUE RUPTURE 3 0.0411
7 BURKHOLDERIA INFECTION 3 0.0361
8 BLASTOCYSTIS INFECTION 3 0.0345
9 CONVULSIVE THRESHOLD LOWERED 13 0.0331
10 RENAL ISCHAEMIA 14 0.0256
11 COLONY STIMULATING FACTOR THERAPY 5 0.0242
12 VACCINATION SITE REACTION 3 0.0233
13 INFUSION SITE VESICLES 10 0.0190
14 CHOLANGITIS INFECTIVE 5 0.0188
15 APPLICATION SITE MASS 5 0.0182
16 PARASOMNIA 13 0.0181
17 INTRAVASCULAR HAEMOLYSIS 10 0.0179
18 ANAEMIA OF MALIGNANT DISEASE 5 0.0179
19 DYSAESTHESIA PHARYNX 3 0.0171
20 POSTURAL TREMOR 5 0.0171
21 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 12 0.0152
22 BASOPHIL COUNT DECREASED 4 0.0151
23 LICE INFESTATION 3 0.0143
24 STROKE IN EVOLUTION 3 0.0135
25 PARENTERAL NUTRITION 3 0.0130
26 IMMUNE-MEDIATED NEPHRITIS 6 0.0128
27 PERIPHERAL VEIN THROMBOSIS 3 0.0126
28 CHOLINERGIC SYNDROME 8 0.0125
29 NAIL PIGMENTATION 3 0.0124
30 SOMATIC DELUSION 3 0.0122
31 ALOPECIA TOTALIS 4 0.0122
32 ACUTE HEPATITIS B 4 0.0120
33 NECROTISING COLITIS 15 0.0118
34 THROMBOPHLEBITIS MIGRANS 4 0.0118
35 BILE ACIDS INCREASED 2 0.0113
36 HAEMOPERITONEUM 9 0.0112
37 AUTOIMMUNE COLITIS 7 0.0109
38 VASCULAR PAIN 9 0.0094
39 AUTOIMMUNE MYOCARDITIS 2 0.0091
40 ALANINE AMINOTRANSFERASE 2 0.0090
41 HYPOPROTEINAEMIA 17 0.0090
42 AORTITIS 6 0.0087
43 FEBRILE INFECTION 10 0.0085
44 CYSTITIS ESCHERICHIA 3 0.0084
45 IMMUNE-MEDIATED CHOLANGITIS 3 0.0084
46 CYSTITIS HAEMORRHAGIC 31 0.0077
47 BETA 2 MICROGLOBULIN INCREASED 2 0.0077
48 NAIL RIDGING 4 0.0076
49 ENTEROCOLITIS INFECTIOUS 7 0.0076
50 ABDOMINAL WOUND DEHISCENCE 2 0.0073
51 STASIS DERMATITIS 5 0.0073
52 MONOCYTE PERCENTAGE INCREASED 5 0.0071
53 ALOPECIA UNIVERSALIS 2 0.0068
54 FULMINANT TYPE 1 DIABETES MELLITUS 7 0.0068
55 HAIR DISORDER 55 0.0067
56 ANASTOMOTIC ULCER 3 0.0065
57 BILIARY TRACT INFECTION 4 0.0064
58 HYPOALBUMINAEMIA 49 0.0063
59 PROCEDURAL VOMITING 4 0.0062
60 PROTEIN-LOSING GASTROENTEROPATHY 3 0.0060
61 PSYCHOLOGICAL TRAUMA 52 0.0060
62 NEUTROPHIL COUNT DECREASED 244 0.0060
63 IMMUNE-MEDIATED DERMATITIS 6 0.0060
64 SUPRAPUBIC PAIN 3 0.0059
65 SEDATION COMPLICATION 15 0.0059
66 HICCUPS 48 0.0058
67 IMMUNE-MEDIATED ENCEPHALITIS 3 0.0057
68 POSTOPERATIVE ILEUS 3 0.0053
69 BLOOD ALKALINE PHOSPHATASE DECREASED 5 0.0053
70 MALIGNANT ASCITES 4 0.0052
71 FEBRILE NEUTROPENIA 343 0.0052
72 AORTIC CALCIFICATION 3 0.0052
73 HAIR COLOUR CHANGES 64 0.0051
74 PROCEDURAL NAUSEA 4 0.0050
75 COLON CANCER METASTATIC 8 0.0050
76 HYPERURICAEMIA 20 0.0049
77 OESOPHAGEAL RUPTURE 4 0.0048
78 HAIR TEXTURE ABNORMAL 64 0.0048
79 MEAN PLATELET VOLUME DECREASED 4 0.0048
80 ARTERITIS 3 0.0047
81 EMBOLISM VENOUS 14 0.0046
82 ALCOHOL WITHDRAWAL SYNDROME 4 0.0046
83 MADAROSIS 53 0.0046
84 TRANSFUSION REACTION 4 0.0046
85 ALOPECIA AREATA 8 0.0046
86 ILEAL PERFORATION 3 0.0045
87 BLADDER HYPERTROPHY 2 0.0045
88 ENTEROCOLITIS 26 0.0045
89 IMMUNE-MEDIATED HEPATITIS 9 0.0044
90 IMMUNE-MEDIATED MYOCARDITIS 7 0.0043
91 ATRIOVENTRICULAR BLOCK SECOND DEGREE 13 0.0043
92 PERIPHERAL MOTOR NEUROPATHY 6 0.0043
93 HYPOCHLORAEMIA 5 0.0043
94 GASTRIC DILATATION 7 0.0042
95 ABDOMINAL MASS 11 0.0041
96 PERIPHERAL SENSORY NEUROPATHY 24 0.0041
97 MYELOSUPPRESSION 147 0.0041
98 DUODENAL PERFORATION 4 0.0041
99 HYPOPHYSITIS 8 0.0040
100 CHOLANGITIS ACUTE 3 0.0040
101 PULMONARY ARTERY THROMBOSIS 3 0.0039
102 CREATINE KINASE INCREASED 3 0.0039
103 IMMUNE THROMBOCYTOPENIC PURPURA 11 0.0039
104 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 3 0.0038
105 IMMUNE-MEDIATED ENTEROCOLITIS 14 0.0038
106 LYMPHOCYTE PERCENTAGE DECREASED 5 0.0037
107 OESOPHAGEAL PERFORATION 3 0.0036
108 RECALL PHENOMENON 3 0.0036
109 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 3 0.0036
110 TONGUE MOVEMENT DISTURBANCE 3 0.0035
111 LYMPHOCYTE COUNT DECREASED 62 0.0035
112 PELVIC ABSCESS 4 0.0035
113 PALMAR ERYTHEMA 4 0.0035
114 NORMOCYTIC ANAEMIA 5 0.0034
115 EXCESSIVE EYE BLINKING 5 0.0034
116 HYPOMAGNESAEMIA 46 0.0033
117 IMMUNE-MEDIATED LUNG DISEASE 6 0.0033
118 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 4 0.0032
119 INFUSION SITE PRURITUS 10 0.0032
120 HAEMORRHAGE URINARY TRACT 8 0.0031
121 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 32 0.0031
122 DACRYOSTENOSIS ACQUIRED 4 0.0031
123 IMMUNE-MEDIATED HEPATIC DISORDER 6 0.0031
124 DRUG CLEARANCE DECREASED 4 0.0031
125 CYTOKINE RELEASE SYNDROME 60 0.0030
126 DERMATITIS ACNEIFORM 18 0.0030
127 HYPOKALAEMIA 136 0.0029
128 NEUTROPENIC SEPSIS 21 0.0029
129 GASTRIC PERFORATION 8 0.0029
130 CORONAVIRUS TEST POSITIVE 3 0.0029
131 DIABETES INSIPIDUS 7 0.0029
132 BACTERAEMIA 34 0.0029
133 VULVOVAGINAL MYCOTIC INFECTION 11 0.0028
134 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 9 0.0027
135 GASTROINTESTINAL PERFORATION 11 0.0026
136 PERIARTHRITIS 6 0.0026
137 IMMUNE-MEDIATED ADVERSE REACTION 4 0.0026
138 STOMA SITE HAEMORRHAGE 4 0.0026
139 AORTIC THROMBOSIS 3 0.0026
140 RADIATION SKIN INJURY 3 0.0026
141 MUCOSAL INFLAMMATION 67 0.0026
142 TUMOUR LYSIS SYNDROME 22 0.0025
143 EMBOLISM ARTERIAL 3 0.0025
144 APLASTIC ANAEMIA 13 0.0025
145 RASH VESICULAR 12 0.0025
146 VESTIBULAR DISORDER 3 0.0024
147 CHOLANGITIS SCLEROSING 5 0.0024
148 RESUSCITATION 4 0.0024
149 ADRENAL MASS 2 0.0024
150 NEUTROPENIA 326 0.0024
151 RESPIRATORY DEPRESSION 29 0.0024
152 MALLORY-WEISS SYNDROME 3 0.0024
153 ROSACEA 11 0.0024
154 NEUROPATHY 4 0.0024
155 ANAEMIA MACROCYTIC 5 0.0023
156 LEUKOPENIA 117 0.0023
157 POLYNEUROPATHY 28 0.0023
158 BILIARY OBSTRUCTION 3 0.0023
159 HYPOPHOSPHATAEMIA 17 0.0023
160 PARONYCHIA 10 0.0023
161 ILEUS PARALYTIC 10 0.0022
162 ADENOCARCINOMA 5 0.0022
163 PNEUMONITIS 60 0.0022
164 ESSENTIAL HYPERTENSION 4 0.0022
165 PNEUMONIA KLEBSIELLA 4 0.0022
166 ADENOCARCINOMA GASTRIC 2 0.0022
167 RENAL TUBULAR DISORDER 6 0.0021
168 EOSINOPHIL COUNT DECREASED 5 0.0021
169 TONGUE OEDEMA 8 0.0021
170 INFUSION RELATED REACTION 139 0.0021
171 CHOLANGITIS 13 0.0021
172 HEPATIC MASS 4 0.0021
173 RHEUMATIC DISORDER 4 0.0021
174 HYPOVOLAEMIA 12 0.0020
175 ORAL CANDIDIASIS 27 0.0020
176 STRIDOR 6 0.0020
177 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
178 VENOOCCLUSIVE DISEASE 5 0.0020
179 TYPE I HYPERSENSITIVITY 7 0.0020
180 URINE ABNORMALITY 9 0.0020
181 PNEUMONIA PSEUDOMONAL 3 0.0020
182 CANCER PAIN 5 0.0020
183 MEAN CELL VOLUME INCREASED 5 0.0019
184 BLADDER DYSFUNCTION 2 0.0019
185 DIVERTICULAR PERFORATION 4 0.0019
186 NEUTROPENIC COLITIS 4 0.0019
187 ILEUS 24 0.0019
188 MONOCYTE COUNT INCREASED 7 0.0019
189 SUBILEUS 4 0.0019
190 ASPARTATE AMINOTRANSFERASE INCREASED 102 0.0019
191 OSTEOSCLEROSIS 3 0.0019
192 STAPHYLOCOCCUS TEST POSITIVE 4 0.0019
193 HYPOVOLAEMIC SHOCK 9 0.0019
194 RADIATION PNEUMONITIS 4 0.0019
195 CYSTITIS INTERSTITIAL 3 0.0019
196 HYPERPHOSPHATAEMIA 4 0.0019
197 PLATELET COUNT DECREASED 198 0.0019
198 ABDOMINAL TENDERNESS 9 0.0018
199 AORTIC DILATATION 2 0.0018
200 RHINOVIRUS INFECTION 7 0.0018
201 MALIGNANT PLEURAL EFFUSION 3 0.0018
202 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 3 0.0018
203 NEUTROPHIL COUNT ABNORMAL 5 0.0018
204 METASTASES TO MENINGES 4 0.0018
205 TUMOUR HAEMORRHAGE 5 0.0018
206 DUODENAL ULCER HAEMORRHAGE 5 0.0017
207 ARTERIOSPASM CORONARY 7 0.0017
208 HYPERAMMONAEMIC ENCEPHALOPATHY 3 0.0017
209 INFUSION SITE INFECTION 4 0.0017
210 NECROTISING FASCIITIS 6 0.0017
211 NEUROPATHY PERIPHERAL 161 0.0017
212 PULSE ABSENT 8 0.0017
213 ODYNOPHAGIA 10 0.0017
214 ANAEMIA 319 0.0017
215 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
216 UPPER GASTROINTESTINAL HAEMORRHAGE 28 0.0017
217 THROMBOCYTOPENIA 186 0.0017
218 STOMATITIS 100 0.0016
219 THROMBOTIC MICROANGIOPATHY 16 0.0016
220 SOFT TISSUE INFECTION 3 0.0016
221 INTERSTITIAL LUNG DISEASE 79 0.0016
222 OESOPHAGEAL SPASM 3 0.0016
223 DIASTOLIC DYSFUNCTION 5 0.0016
224 GRANULOCYTE COUNT DECREASED 3 0.0016
225 DIVERTICULUM INTESTINAL 7 0.0016
226 HYPERAMMONAEMIA 8 0.0016
227 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 37 0.0016
228 METASTASES TO PERITONEUM 4 0.0016
229 HEPATITIS B REACTIVATION 5 0.0016
230 CARDIOTOXICITY 14 0.0016
231 CARCINOEMBRYONIC ANTIGEN INCREASED 3 0.0015
232 PNEUMONIA CYTOMEGALOVIRAL 3 0.0015
233 WHITE BLOOD CELL COUNT DECREASED 167 0.0015
234 VENOUS THROMBOSIS 6 0.0015
235 HYPERAEMIA 3 0.0015
236 PNEUMONIA STAPHYLOCOCCAL 3 0.0015
237 ALANINE AMINOTRANSFERASE INCREASED 93 0.0015
238 MUCOSAL DRYNESS 3 0.0015
239 METASTASES TO SPINE 5 0.0015
240 LARYNGOSPASM 4 0.0015
241 OSTEOLYSIS 3 0.0015
242 GASTROINTESTINAL TOXICITY 7 0.0015
243 VENOUS THROMBOSIS LIMB 3 0.0015
244 BLOOD LACTATE DEHYDROGENASE INCREASED 23 0.0015
245 EMBOLISM 12 0.0014
246 ALOPECIA 283 0.0014
247 ALTERED STATE OF CONSCIOUSNESS 31 0.0014
248 DEVICE RELATED INFECTION 22 0.0014
249 PROCTITIS 4 0.0014
250 DILATATION VENTRICULAR 3 0.0014
251 HYPOCALCAEMIA 27 0.0014
252 ACUTE PULMONARY OEDEMA 8 0.0014
253 INFUSION SITE ERYTHEMA 12 0.0014
254 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
255 SINUS TACHYCARDIA 20 0.0014
256 FIBRIN D DIMER INCREASED 5 0.0014
257 PANCREATIC CARCINOMA METASTATIC 4 0.0014
258 BRAIN FOG 22 0.0014
259 IMPAIRED QUALITY OF LIFE 20 0.0014
260 BONE LESION 5 0.0014
261 VISUAL FIELD DEFECT 10 0.0014
262 BONE MARROW FAILURE 28 0.0014
263 GASTROINTESTINAL NECROSIS 4 0.0014
264 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
265 METASTASES TO LIVER 24 0.0014
266 CLOSTRIDIUM TEST POSITIVE 3 0.0014
267 APPETITE DISORDER 9 0.0014
268 HYPERBILIRUBINAEMIA 14 0.0014
269 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 8 0.0013
270 VENTRICULAR FIBRILLATION 15 0.0013
271 FAILURE TO THRIVE 7 0.0013
272 HAEMOLYTIC ANAEMIA 12 0.0013
273 IMMUNE THROMBOCYTOPENIA 6 0.0013
274 HYPOXIA 46 0.0013
275 DUODENITIS 4 0.0013
276 GINGIVITIS 7 0.0013
277 ASCITES 38 0.0013
278 MALIGNANT NEOPLASM PROGRESSION 132 0.0013
279 SPINAL CORD COMPRESSION 5 0.0013
280 PULMONARY TOXICITY 9 0.0013
281 SKIN ABRASION 6 0.0013
282 BLOOD ALBUMIN DECREASED 10 0.0013
283 HYPONATRAEMIA 71 0.0013
284 OESOPHAGEAL CANDIDIASIS 5 0.0013
285 ENTERITIS 8 0.0012
286 IMMUNOSUPPRESSION 11 0.0012
287 LOOSE TOOTH 4 0.0012
288 HEPATITIS ACUTE 8 0.0012
289 DECREASED APPETITE 285 0.0012
290 HAEMATOLOGICAL INFECTION 3 0.0012
291 SMALL INTESTINAL OBSTRUCTION 15 0.0012
292 PANCYTOPENIA 68 0.0012
293 DRUG-INDUCED LIVER INJURY 38 0.0012
294 BLOOD ALKALINE PHOSPHATASE INCREASED 30 0.0012
295 DISSEMINATED INTRAVASCULAR COAGULATION 17 0.0012
296 INFREQUENT BOWEL MOVEMENTS 3 0.0012
297 PERSECUTORY DELUSION 3 0.0012
298 VENTRICULAR HYPERTROPHY 3 0.0012
299 COLITIS ISCHAEMIC 8 0.0012
300 BLOOD CHLORIDE DECREASED 3 0.0012
301 LEUKOCYTOSIS 21 0.0012
302 ACUTE SINUSITIS 2 0.0012
303 METASTATIC NEOPLASM 5 0.0012
304 SKIN NECROSIS 6 0.0012
305 ADRENAL INSUFFICIENCY 14 0.0012
306 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
307 OXYGEN SATURATION DECREASED 64 0.0011
308 JAUNDICE CHOLESTATIC 4 0.0011
309 LYMPHOPENIA 16 0.0011
310 GINGIVAL PAIN 9 0.0011
311 COMPRESSION FRACTURE 6 0.0011
312 ELECTROLYTE IMBALANCE 13 0.0011
313 ANAL ABSCESS 6 0.0011
314 BLOOD SODIUM INCREASED 3 0.0011
315 HEPATIC FAILURE 33 0.0011
316 BLOOD PHOSPHORUS DECREASED 4 0.0011
317 MOUTH ULCERATION 23 0.0011
318 BLOOD BILIRUBIN INCREASED 29 0.0011
319 HEPATIC FUNCTION ABNORMAL 40 0.0011
320 EAR DISCOMFORT 11 0.0011
321 DRUG TOLERANCE DECREASED 3 0.0011
322 BLOOD BICARBONATE DECREASED 2 0.0011
323 CARDIAC TAMPONADE 5 0.0011
324 LUNG CANCER METASTATIC 3 0.0010
325 ESCHERICHIA SEPSIS 3 0.0010
326 ARTERIAL THROMBOSIS 2 0.0010
327 GUILLAIN-BARRE SYNDROME 5 0.0010
328 CONSTIPATION 225 0.0010
329 COLITIS 39 0.0010
330 EYE MOVEMENT DISORDER 7 0.0010
331 HAEMATURIA 35 0.0010
332 STAPHYLOCOCCAL SEPSIS 5 0.0010
333 METASTASES TO CENTRAL NERVOUS SYSTEM 13 0.0010
334 CHOLECYSTITIS 12 0.0010
335 ANORECTAL DISORDER 2 0.0010
336 ATYPICAL PNEUMONIA 3 0.0010
337 FLUID INTAKE REDUCED 5 0.0010
338 THYROIDITIS 3 0.0010
339 LUNG ADENOCARCINOMA 3 0.0010
340 OROPHARYNGEAL DISCOMFORT 9 0.0010
341 PNEUMOCYSTIS JIROVECII PNEUMONIA 10 0.0010
342 KLEBSIELLA INFECTION 5 0.0010
343 ORAL PAIN 22 0.0010
344 HYPOPHAGIA 25 0.0010
345 PHLEBITIS 5 0.0010
346 PORTAL HYPERTENSION 3 0.0010
347 ANAPHYLACTOID REACTION 4 0.0010
348 GASTROENTERITIS 14 0.0010
349 MULTIPLE ORGAN DYSFUNCTION SYNDROME 27 0.0010
350 NON-CARDIAC CHEST PAIN 3 0.0009
351 VASCULITIS 11 0.0009
352 FOREIGN BODY SENSATION IN EYES 6 0.0009
353 HAEMOGLOBIN ABNORMAL 6 0.0009
354 LIVER ABSCESS 3 0.0009
355 THROAT TIGHTNESS 25 0.0009
356 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
357 BACTERIAL SEPSIS 3 0.0009
358 HYPOVENTILATION 3 0.0009
359 HEPATIC NEOPLASM 3 0.0009
360 THROMBOSIS IN DEVICE 3 0.0009
361 NAIL DISORDER 8 0.0009
362 INTESTINAL ISCHAEMIA 5 0.0009
363 C-REACTIVE PROTEIN INCREASED 33 0.0009
364 HAEMOLYSIS 7 0.0009
365 DISEASE PROGRESSION 107 0.0009
366 PURPURA 8 0.0009
367 GAMMA-GLUTAMYLTRANSFERASE INCREASED 20 0.0009
368 PRESCRIBED UNDERDOSE 18 0.0009
369 BACTERIAL TEST POSITIVE 2 0.0009
370 TONGUE ULCERATION 3 0.0009
371 FLUSHING 90 0.0009
372 SEROTONIN SYNDROME 17 0.0009
373 SKIN TOXICITY 5 0.0009
374 ACUTE RESPIRATORY FAILURE 17 0.0009
375 CHOLECYSTITIS ACUTE 5 0.0009
376 PERONEAL NERVE PALSY 5 0.0009
377 INTERNATIONAL NORMALISED RATIO ABNORMAL 3 0.0009
378 TEMPERATURE INTOLERANCE 9 0.0009
379 APLASIA PURE RED CELL 3 0.0009
380 PNEUMONIA BACTERIAL 8 0.0009
381 PERITONITIS 18 0.0009
382 UROSEPSIS 8 0.0009
383 BLOOD PRESSURE DIASTOLIC INCREASED 4 0.0009
384 METASTASES TO LUNG 10 0.0009
385 LARGE INTESTINE PERFORATION 6 0.0009
386 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
387 ERYTHEMA MULTIFORME 8 0.0009
388 TOXIC EPIDERMAL NECROLYSIS 13 0.0009
389 THROMBOPHLEBITIS 3 0.0009
390 DEHYDRATION 114 0.0009
391 SKIN REACTION 12 0.0009
392 SKIN TIGHTNESS 4 0.0008
393 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
394 PANCREATITIS ACUTE 19 0.0008
395 ACUTE CORONARY SYNDROME 7 0.0008
396 SEPSIS 94 0.0008
397 GASTRIC ULCER 16 0.0008
398 BRONCHOSPASM 12 0.0008
399 MUSCULOSKELETAL CHEST PAIN 13 0.0008
400 DELIRIUM 29 0.0008
401 FACIAL BONES FRACTURE 3 0.0008
402 TYPE 1 DIABETES MELLITUS 5 0.0008
403 PYREXIA 287 0.0008
404 ATELECTASIS 8 0.0008
405 ENTEROCOCCAL INFECTION 4 0.0008
406 DYSARTHRIA 31 0.0008
407 CYTOPENIA 10 0.0008
408 ACUTE KIDNEY INJURY 124 0.0008
409 HYPERVOLAEMIA 4 0.0008
410 HAEMATOCRIT DECREASED 16 0.0008
411 PROTEIN URINE PRESENT 4 0.0008
412 CHRONIC SINUSITIS 3 0.0008
413 PROTEIN TOTAL DECREASED 3 0.0008
414 BLEPHAROSPASM 5 0.0008
415 CATHETER SITE INFECTION 3 0.0008
416 CHEMOTHERAPY 3 0.0008
417 TASTE DISORDER 16 0.0008
418 TACHYCARDIA 70 0.0008
419 VENTRICULAR TACHYCARDIA 13 0.0008
420 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
421 ABDOMINAL INFECTION 2 0.0008
422 PROCTALGIA 5 0.0008
423 AORTIC ARTERIOSCLEROSIS 2 0.0008
424 NAUSEA 610 0.0008
425 CANDIDA INFECTION 13 0.0008
426 EPIGASTRIC DISCOMFORT 3 0.0008
427 VOMITING 361 0.0008
428 HYPOGAMMAGLOBULINAEMIA 5 0.0008
429 HYPERTHYROIDISM 11 0.0008
430 BLOOD LACTIC ACID INCREASED 4 0.0008
431 SEPTIC SHOCK 33 0.0008
432 ATRIAL FLUTTER 6 0.0008
433 CARDIAC FAILURE ACUTE 5 0.0007
434 FUNGAL SKIN INFECTION 3 0.0007
435 ANAPHYLACTIC REACTION 41 0.0007
436 HYPERGLYCAEMIA 27 0.0007
437 METASTASES TO LYMPH NODES 5 0.0007
438 PLEURAL EFFUSION 45 0.0007
439 ANAPHYLACTIC SHOCK 19 0.0007
440 PROTEINURIA 14 0.0007
441 DRUG ERUPTION 13 0.0007
442 EXTRAVASATION 3 0.0007
443 RESPIRATORY FAILURE 53 0.0007
444 AORTIC DISSECTION 3 0.0007
445 AUTOIMMUNE HEPATITIS 5 0.0007
446 CARDIO-RESPIRATORY ARREST 30 0.0007
447 OEDEMA PERIPHERAL 87 0.0007
448 INTESTINAL PERFORATION 8 0.0007
449 BLOOD TEST ABNORMAL 10 0.0007
450 FACE OEDEMA 12 0.0007
451 HOSPICE CARE 7 0.0007
452 HYPERPYREXIA 3 0.0007
453 LUNG INFECTION 11 0.0007
454 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
455 CIRCULATORY COLLAPSE 12 0.0007
456 NEUTROPHILIA 4 0.0007
457 CHEST DISCOMFORT 72 0.0007
458 EPISTAXIS 52 0.0007
459 PNEUMOTHORAX 11 0.0007
460 PYELONEPHRITIS 6 0.0007
461 OCULAR ICTERUS 3 0.0007
462 PRODUCTIVE COUGH 33 0.0007
463 MONOPLEGIA 3 0.0007
464 RASH PUSTULAR 5 0.0007
465 ONYCHOMYCOSIS 3 0.0007
466 NEUTROPHIL COUNT INCREASED 7 0.0007
467 MOUTH HAEMORRHAGE 5 0.0007
468 COLD SWEAT 12 0.0007
469 ABDOMINAL ABSCESS 3 0.0007
470 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
471 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
472 RASH MACULO-PAPULAR 15 0.0007
473 COLON CANCER 10 0.0007
474 MYOSITIS 6 0.0007
475 MENINGITIS ASEPTIC 3 0.0007
476 HEPATITIS 17 0.0007
477 PAPILLOEDEMA 3 0.0007
478 SUSPECTED OFF LABEL USE 3 0.0007
479 INCONTINENCE 7 0.0007
480 DEEP VEIN THROMBOSIS 43 0.0007
481 BLOOD UREA INCREASED 11 0.0007
482 HYPERKALAEMIA 23 0.0007
483 CHRONIC MYELOID LEUKAEMIA 3 0.0006
484 UPPER RESPIRATORY TRACT INFECTION 30 0.0006
485 PERICARDIAL EFFUSION 15 0.0006
486 HAEMOPTYSIS 18 0.0006
487 GASTRITIS EROSIVE 3 0.0006
488 HYPOTENSION 129 0.0006
489 INFUSION SITE EXTRAVASATION 4 0.0006
490 APPENDICITIS 6 0.0006
491 ACUTE MYELOID LEUKAEMIA 10 0.0006
492 ABDOMINAL PAIN 149 0.0006
493 FLANK PAIN 6 0.0006
494 PNEUMONIA 205 0.0006
495 PHOTOPSIA 4 0.0006
496 STEVENS-JOHNSON SYNDROME 14 0.0006
497 SUBCUTANEOUS ABSCESS 3 0.0006
498 MALNUTRITION 7 0.0006
499 NEPHROPATHY TOXIC 7 0.0006
500 APHAGIA 3 0.0006
501 HYPERCHOLESTEROLAEMIA 6 0.0006
502 UNRESPONSIVE TO STIMULI 16 0.0006
503 FEELING HOT 38 0.0006
504 HAEMATOCHEZIA 34 0.0006
505 HAEMORRHOIDS 12 0.0006
506 ASPHYXIA 5 0.0006
507 SEDATION 16 0.0006
508 HEPATOMEGALY 6 0.0006
509 NEOPLASM PROGRESSION 21 0.0006
510 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 3 0.0006
511 HYPERNATRAEMIA 3 0.0006
512 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
513 CHILLS 70 0.0006
514 RED BLOOD CELL COUNT DECREASED 17 0.0006
515 CARDIAC ARREST 49 0.0006
516 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
517 AGRANULOCYTOSIS 11 0.0006
518 PATHOLOGICAL FRACTURE 3 0.0006
519 B-CELL LYMPHOMA 2 0.0006
520 AKATHISIA 8 0.0006
521 DRUG INTERACTION 93 0.0006
522 SYNCOPE 58 0.0006
523 EJECTION FRACTION DECREASED 9 0.0006
524 ENCEPHALITIS 4 0.0006
525 TONSILLITIS 3 0.0006
526 DIARRHOEA 370 0.0006
527 CEREBRAL INFARCTION 14 0.0006
528 GASTRITIS 15 0.0006
529 URINARY RETENTION 19 0.0006
530 SERUM FERRITIN INCREASED 3 0.0006
531 DUODENAL ULCER 4 0.0006
532 HYPERCALCAEMIA 7 0.0006
533 LUNG INFILTRATION 5 0.0006
534 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
535 HYPOTHYROIDISM 18 0.0006
536 EATING DISORDER 12 0.0006
537 LACRIMATION INCREASED 17 0.0006
538 METASTASIS 4 0.0006
539 DERMATITIS ALLERGIC 7 0.0006
540 DERMATITIS BULLOUS 4 0.0006
541 PALLOR 15 0.0006
542 ACUTE MYOCARDIAL INFARCTION 16 0.0005
543 ASTHENIA 204 0.0005
544 PULMONARY MASS 8 0.0005
545 ANGIOPATHY 3 0.0005
546 DIARRHOEA HAEMORRHAGIC 5 0.0005
547 SKIN INFECTION 6 0.0005
548 HYDRONEPHROSIS 4 0.0005
549 HYPOAESTHESIA ORAL 8 0.0005
550 LIVER INJURY 13 0.0005
551 OROPHARYNGEAL PAIN 49 0.0005
552 MYOCARDIAL ISCHAEMIA 6 0.0005
553 DYSGEUSIA 39 0.0005
554 LIPASE INCREASED 4 0.0005
555 MUSCLE TWITCHING 12 0.0005
556 BLOOD URIC ACID INCREASED 3 0.0005
557 CELLULITIS 26 0.0005
558 RETCHING 11 0.0005
559 BRONCHOPULMONARY ASPERGILLOSIS 4 0.0005
560 NEUROTOXICITY 9 0.0005
561 GINGIVAL BLEEDING 7 0.0005
562 HYPERTRIGLYCERIDAEMIA 3 0.0005
563 SINUS HEADACHE 3 0.0005
564 ORAL DISCOMFORT 7 0.0005
565 TRICUSPID VALVE INCOMPETENCE 4 0.0005
566 AZOTAEMIA 2 0.0005
567 BLEPHARITIS 2 0.0005
568 HEPATITIS B 3 0.0005
569 RHINITIS 4 0.0005
570 FEEDING DISORDER 10 0.0005
571 DECUBITUS ULCER 4 0.0005
572 CHROMATURIA 11 0.0005
573 ESCHERICHIA INFECTION 4 0.0005
574 PARAESTHESIA ORAL 7 0.0005
575 LIMB DISCOMFORT 15 0.0005
576 JAUNDICE 13 0.0005
577 CYTOMEGALOVIRUS INFECTION 8 0.0005
578 HEMIPLEGIA 4 0.0005
579 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
580 NASAL DRYNESS 3 0.0005
581 BONE PAIN 28 0.0005
582 HAEMATEMESIS 12 0.0005
583 BACK PAIN 109 0.0005
584 MENTAL STATUS CHANGES 13 0.0005
585 ERYTHEMA 96 0.0005
586 SKIN HYPERPIGMENTATION 4 0.0005
587 SKIN ULCER 12 0.0005
588 EAR PAIN 9 0.0005
589 DYSURIA 17 0.0005
590 HERPES SIMPLEX 3 0.0005
591 OESOPHAGITIS 5 0.0005
592 LYMPHOMA 7 0.0005
593 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
594 PULMONARY EMBOLISM 43 0.0005
595 PRESYNCOPE 11 0.0005
596 PARAESTHESIA 71 0.0005
597 RESPIRATORY RATE INCREASED 4 0.0005
598 TRANSAMINASES INCREASED 10 0.0004
599 SKIN MASS 3 0.0004
600 HAEMOGLOBIN DECREASED 46 0.0004
601 ENCEPHALOPATHY 11 0.0004
602 BREAST MASS 3 0.0004
603 FATIGUE 345 0.0004
604 GASTROINTESTINAL HAEMORRHAGE 37 0.0004
605 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
606 DYSPNOEA 250 0.0004
607 ABDOMINAL HERNIA 2 0.0004
608 ECCHYMOSIS 3 0.0004
609 NEOPLASM 5 0.0004
610 OVARIAN CANCER 4 0.0004
611 IRON DEFICIENCY ANAEMIA 4 0.0004
612 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
613 ATRIAL FIBRILLATION 42 0.0004
614 CONJUNCTIVITIS 8 0.0004
615 HYPERTENSION 91 0.0004
616 DERMATITIS 9 0.0004
617 LIVER DISORDER 19 0.0004
618 CHEST PAIN 79 0.0004
619 METASTASES TO BONE 7 0.0004
620 PAPULE 3 0.0004
621 BLOOD SODIUM DECREASED 8 0.0004
622 LYMPHADENOPATHY 15 0.0004
623 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
624 DYSPHAGIA 40 0.0004
625 HYPERHIDROSIS 54 0.0004
626 DIABETIC KETOACIDOSIS 10 0.0004
627 GENERAL PHYSICAL HEALTH DETERIORATION 48 0.0004
628 SINUS BRADYCARDIA 4 0.0004
629 THERAPY CHANGE 4 0.0004
630 OEDEMA 22 0.0004
631 THROAT IRRITATION 18 0.0004
632 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
633 BLOOD POTASSIUM DECREASED 12 0.0004
634 DYSPNOEA EXERTIONAL 15 0.0004
635 AMMONIA INCREASED 2 0.0004
636 SHOCK 9 0.0004
637 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
638 INITIAL INSOMNIA 4 0.0004
639 ATRIOVENTRICULAR BLOCK 3 0.0004
640 INFUSION SITE PAIN 5 0.0004
641 URINARY TRACT INFECTION 66 0.0004
642 OFF LABEL USE 338 0.0004
643 THERAPY PARTIAL RESPONDER 6 0.0004
644 POLLAKIURIA 16 0.0004
645 PULMONARY HAEMORRHAGE 3 0.0004
646 PLATELET COUNT INCREASED 5 0.0004
647 BLOOD CREATININE INCREASED 25 0.0004
648 CYANOSIS 6 0.0004
649 RENAL IMPAIRMENT 32 0.0004
650 HYPOAESTHESIA 57 0.0004
651 FURUNCLE 3 0.0004
652 ANAL FISTULA 2 0.0004
653 ABDOMINAL DISTENSION 39 0.0004
654 PAIN OF SKIN 10 0.0004
655 LACTIC ACIDOSIS 12 0.0004
656 SHOCK HAEMORRHAGIC 3 0.0004
657 GASTROINTESTINAL DISORDER 33 0.0004
658 SKIN LACERATION 4 0.0004
659 TACHYPNOEA 5 0.0004
660 ABNORMAL FAECES 3 0.0004
661 WOUND INFECTION 4 0.0004
662 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
663 MELAENA 8 0.0004
664 ERUCTATION 7 0.0004
665 THROMBOSIS 29 0.0004
666 COAGULOPATHY 6 0.0004
667 EOSINOPHIL COUNT INCREASED 3 0.0004
668 RHABDOMYOLYSIS 15 0.0004
669 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
670 PULMONARY OEDEMA 16 0.0004
671 SENSATION OF FOREIGN BODY 3 0.0004
672 RESTLESSNESS 13 0.0004
673 MITRAL VALVE INCOMPETENCE 4 0.0004
674 FLATULENCE 20 0.0004
675 HEPATOCELLULAR INJURY 5 0.0004
676 SWOLLEN TONGUE 11 0.0004
677 BLOOD MAGNESIUM DECREASED 3 0.0003
678 FULL BLOOD COUNT DECREASED 7 0.0003
679 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
680 SEIZURE 40 0.0003
681 CYSTITIS 11 0.0003
682 WEIGHT DECREASED 96 0.0003
683 EOSINOPHILIA 6 0.0003
684 SPINAL OSTEOARTHRITIS 3 0.0003
685 SPLENOMEGALY 4 0.0003
686 COVID-19 PNEUMONIA 4 0.0003
687 URINARY INCONTINENCE 10 0.0003
688 ATAXIA 4 0.0003
689 HAEMORRHAGE INTRACRANIAL 5 0.0003
690 RENAL FAILURE ACUTE 14 0.0003
691 SKIN DISORDER 11 0.0003
692 INCREASED TENDENCY TO BRUISE 3 0.0003
693 CARDIAC FAILURE 26 0.0003
694 HYPERSENSITIVITY 60 0.0003
695 GENERALISED OEDEMA 4 0.0003
696 PHARYNGITIS 4 0.0003
697 EXTRAPYRAMIDAL DISORDER 8 0.0003
698 EMOTIONAL DISTRESS 39 0.0003
699 HEPATIC STEATOSIS 6 0.0003
700 BACTERIAL INFECTION 6 0.0003
701 NEPHROPATHY 3 0.0003
702 BLOOD PRESSURE INCREASED 49 0.0003
703 PNEUMONIA ASPIRATION 8 0.0003
704 PHOTOPHOBIA 6 0.0003
705 INTESTINAL OBSTRUCTION 12 0.0003
706 BRAIN OEDEMA 4 0.0003
707 ANGIOEDEMA 14 0.0003
708 DEATH 271 0.0003
709 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
710 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
711 PRESCRIBED OVERDOSE 6 0.0003
712 CONFUSIONAL STATE 50 0.0003
713 RESPIRATORY TRACT INFECTION 8 0.0003
714 SKIN FISSURES 6 0.0003
715 PHARYNGEAL SWELLING 3 0.0003
716 ABDOMINAL PAIN UPPER 63 0.0003
717 DEAFNESS 8 0.0003
718 RENAL TUBULAR NECROSIS 3 0.0003
719 SPEECH DISORDER 16 0.0003
720 JOINT STIFFNESS 8 0.0003
721 WHEEZING 18 0.0003
722 IMMUNE SYSTEM DISORDER 4 0.0003
723 STAPHYLOCOCCAL INFECTION 10 0.0003
724 DRUG INTOLERANCE 29 0.0003
725 SALIVARY HYPERSECRETION 3 0.0003
726 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
727 PAIN IN EXTREMITY 87 0.0003
728 DYSKINESIA 12 0.0003
729 HEMIPARESIS 5 0.0003
730 TOOTH ABSCESS 3 0.0003
731 ACUTE HEPATIC FAILURE 4 0.0003
732 PERIPHERAL COLDNESS 4 0.0003
733 DYSPHONIA 17 0.0003
734 MUSCULAR WEAKNESS 33 0.0003
735 RESPIRATORY ARREST 8 0.0003
736 RESPIRATORY DISTRESS 8 0.0003
737 VENTRICULAR EXTRASYSTOLES 3 0.0003
738 DIVERTICULITIS 8 0.0003
739 TENDERNESS 3 0.0003
740 PETECHIAE 3 0.0003
741 ORTHOSTATIC HYPOTENSION 5 0.0003
742 RASH 125 0.0003
743 BLOOD PRESSURE DECREASED 19 0.0003
744 SUDDEN DEATH 3 0.0003
745 SUBDURAL HAEMATOMA 4 0.0003
746 BREAST CANCER METASTATIC 3 0.0003
747 DEPRESSED LEVEL OF CONSCIOUSNESS 11 0.0003
748 MYELODYSPLASTIC SYNDROME 4 0.0003
749 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
750 LIVER FUNCTION TEST ABNORMAL 8 0.0003
751 DYSPEPSIA 27 0.0003
752 PRODUCT USE IN UNAPPROVED INDICATION 68 0.0003
753 DYSSTASIA 8 0.0003
754 BLINDNESS TRANSIENT 2 0.0003
755 RENAL FAILURE 36 0.0003
756 LABORATORY TEST ABNORMAL 8 0.0003
757 HEPATOTOXICITY 6 0.0003
758 IMMUNODEFICIENCY 4 0.0003
759 BLOOD COUNT ABNORMAL 4 0.0003
760 URTICARIA 44 0.0003
761 MICTURITION URGENCY 3 0.0003
762 ABDOMINAL DISCOMFORT 44 0.0003
763 DISCOMFORT 16 0.0003
764 GASTRIC HAEMORRHAGE 3 0.0003
765 CHOLESTASIS 5 0.0003
766 COUGH 73 0.0003
767 PRURITUS 100 0.0003
768 MYALGIA 44 0.0003
769 MALAISE 111 0.0003
770 MYOCLONUS 3 0.0003
771 ULCER 4 0.0003
772 RASH ERYTHEMATOUS 12 0.0003
773 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
774 LOSS OF CONSCIOUSNESS 32 0.0002
775 DIZZINESS 123 0.0002
776 UNDERDOSE 18 0.0002
777 ANXIETY 70 0.0002
778 PANCREATITIS 13 0.0002
779 PANCREATIC CARCINOMA 7 0.0002
780 TOOTH EXTRACTION 3 0.0002
781 AGEUSIA 6 0.0002
782 TINNITUS 11 0.0002
783 TYPE 2 DIABETES MELLITUS 8 0.0002
784 GASTROOESOPHAGEAL REFLUX DISEASE 19 0.0002
785 NECK PAIN 13 0.0002
786 MUSCULOSKELETAL DISCOMFORT 4 0.0002
787 HYPOACUSIS 10 0.0002
788 MULTI-ORGAN FAILURE 4 0.0002
789 FAECES DISCOLOURED 5 0.0002
790 PALPITATIONS 27 0.0002
791 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
792 LOCAL SWELLING 4 0.0002
793 MUSCULOSKELETAL PAIN 12 0.0002
794 TREMOR 38 0.0002
795 INFECTION 33 0.0002
796 LUNG DISORDER 11 0.0002
797 ISCHAEMIC STROKE 4 0.0002
798 THIRST 4 0.0002
799 SINUS CONGESTION 3 0.0002
800 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40 0.0002
801 NASAL CONGESTION 13 0.0002
802 PELVIC PAIN 4 0.0002
803 HAEMORRHAGE 23 0.0002
804 PERIPHERAL SWELLING 33 0.0002
805 DEVICE OCCLUSION 3 0.0002
806 INFLAMMATION 11 0.0002
807 PAIN IN JAW 6 0.0002
808 CARDIAC FAILURE CONGESTIVE 17 0.0002
809 CONVULSION 12 0.0002
810 DYSTONIA 4 0.0002
811 APATHY 3 0.0002
812 RASH PRURITIC 11 0.0002
813 OESOPHAGEAL CARCINOMA 6 0.0002
814 OSTEONECROSIS OF JAW 5 0.0002
815 SLEEP DISORDER 14 0.0002
816 ABDOMINAL PAIN LOWER 5 0.0002
817 CARDIOVASCULAR DISORDER 5 0.0002
818 EPILEPSY 6 0.0002
819 RASH GENERALISED 5 0.0002
820 HAEMATOMA 5 0.0002
821 INSOMNIA 51 0.0002
822 LETHARGY 11 0.0002
823 VISION BLURRED 26 0.0002
824 OSTEOARTHRITIS 8 0.0002
825 BRADYCARDIA 10 0.0002
826 PREMATURE DELIVERY 3 0.0002
827 LIVER FUNCTION TEST INCREASED 4 0.0002
828 RECTAL HAEMORRHAGE 8 0.0002
829 POOR QUALITY SLEEP 4 0.0002
830 RHINORRHOEA 12 0.0002
831 BLOOD POTASSIUM INCREASED 3 0.0002
832 PRODUCT PRESCRIBING ISSUE 4 0.0002
833 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
834 CHOLELITHIASIS 6 0.0002
835 ASPIRATION 2 0.0002
836 COVID-19 32 0.0002
837 MANIA 3 0.0002
838 VISUAL ACUITY REDUCED 6 0.0002
839 FUNGAL INFECTION 6 0.0002
840 WOUND 5 0.0002
841 SOMNOLENCE 36 0.0002
842 BLOOD CALCIUM DECREASED 2 0.0002
843 GAIT DISTURBANCE 34 0.0002
844 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
845 SCAR 3 0.0002
846 JOINT SWELLING 21 0.0002
847 DRY MOUTH 14 0.0002
848 BLINDNESS 7 0.0002
849 RENAL DISORDER 8 0.0002
850 HEART RATE INCREASED 17 0.0002
851 ARRHYTHMIA 8 0.0002
852 DISEASE RECURRENCE 8 0.0002
853 PAIN 103 0.0002
854 RESPIRATORY DISORDER 5 0.0002
855 SKIN EXFOLIATION 14 0.0002
856 OSTEOMYELITIS 3 0.0002
857 APHASIA 5 0.0002
858 BONE DISORDER 3 0.0002
859 END STAGE RENAL DISEASE 3 0.0002
860 HEADACHE 103 0.0002
861 ARTHRALGIA 68 0.0002
862 MUSCLE SPASMS 30 0.0002
863 DEPRESSION 37 0.0002
864 INJECTION SITE MASS 6 0.0002
865 HEPATIC ENZYME INCREASED 11 0.0002
866 EYE SWELLING 6 0.0002
867 APPLICATION SITE IRRITATION 2 0.0002
868 BLISTER 9 0.0002
869 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
870 FRACTURE 3 0.0002
871 HERPES ZOSTER 9 0.0002
872 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
873 THERAPY CESSATION 8 0.0002
874 CONTUSION 15 0.0002
875 PRODUCT USE ISSUE 29 0.0002
876 DEPRESSED MOOD 8 0.0002
877 VIRAL INFECTION 5 0.0002
878 SPINAL FRACTURE 3 0.0001
879 GAIT INABILITY 5 0.0001
880 SWELLING 14 0.0001
881 FEAR 4 0.0001
882 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
883 RIB FRACTURE 3 0.0001
884 SKIN LESION 4 0.0001
885 PULMONARY HYPERTENSION 3 0.0001
886 FEELING COLD 4 0.0001
887 DEMENTIA 4 0.0001
888 INTENTIONAL DOSE OMISSION 4 0.0001
889 SWELLING FACE 9 0.0001
890 CONDITION AGGRAVATED 42 0.0001
891 FLUID RETENTION 7 0.0001
892 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
893 TOOTH DISORDER 3 0.0001
894 RASH PAPULAR 3 0.0001
895 PREMATURE BABY 4 0.0001
896 HALLUCINATION 10 0.0001
897 SKIN DISCOLOURATION 6 0.0001
898 OCULAR HYPERAEMIA 6 0.0001
899 THERAPY INTERRUPTED 9 0.0001
900 ABSCESS 2 0.0001
901 METABOLIC ACIDOSIS 4 0.0001
902 NASOPHARYNGITIS 23 0.0001
903 NIGHT SWEATS 4 0.0001
904 OSTEONECROSIS 4 0.0001
905 LUNG NEOPLASM MALIGNANT 5 0.0001
906 OSTEOPOROSIS 5 0.0001
907 FEELING ABNORMAL 29 0.0001
908 LIP SWELLING 4 0.0001
909 NEOPLASM MALIGNANT 8 0.0001
910 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
911 GASTRIC DISORDER 4 0.0001
912 BALANCE DISORDER 10 0.0001
913 DIPLOPIA 3 0.0001
914 APPLICATION SITE ERYTHEMA 3 0.0001
915 RASH MACULAR 4 0.0001
916 BURNING SENSATION 8 0.0001
917 AMENORRHOEA 2 0.0001
918 HEART RATE DECREASED 4 0.0001
919 THERAPY NON-RESPONDER 5 0.0001
920 CRYING 4 0.0001
921 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
922 MYOCARDIAL INFARCTION 19 0.0001
923 PROCEDURAL PAIN 3 0.0001
924 ACNE 8 0.0001
925 HYPERSOMNIA 3 0.0001
926 RENAL INJURY 3 0.0001
927 DISORIENTATION 4 0.0001
928 TOXICITY TO VARIOUS AGENTS 17 0.0001
929 CEREBROVASCULAR ACCIDENT 17 0.0001
930 ADVERSE EVENT 9 0.0001
931 EMOTIONAL DISORDER 3 0.0001
932 INFLUENZA LIKE ILLNESS 8 0.0001
933 VISUAL IMPAIRMENT 12 0.0001
934 FALL 32 0.0001
935 NERVOUS SYSTEM DISORDER 3 0.0001
936 MEMORY IMPAIRMENT 13 0.0001
937 MOOD SWINGS 3 0.0001
938 MOVEMENT DISORDER 3 0.0001
939 DRUG EFFECT DECREASED 5 0.0001
940 MENTAL DISORDER 4 0.0001
941 DRY SKIN 12 0.0001
942 EYE PRURITUS 3 0.0001
943 SINUSITIS 9 0.0001
944 EYE IRRITATION 5 0.0001
945 COGNITIVE DISORDER 4 0.0001
946 MIGRAINE 8 0.0001
947 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
948 IRRITABILITY 5 0.0001
949 HYPOGLYCAEMIA 4 0.0001
950 THERAPEUTIC RESPONSE DECREASED 5 0.0001
951 ACCIDENTAL OVERDOSE 3 0.0001
952 AGITATION 6 0.0001
953 BRONCHITIS 6 0.0001
954 EXPOSURE DURING PREGNANCY 5 0.0001
955 WEIGHT INCREASED 18 0.0001
956 DRY EYE 4 0.0001
957 CHRONIC KIDNEY DISEASE 6 0.0001
958 DIABETES MELLITUS 6 0.0001
959 PLASMA CELL MYELOMA 3 0.0001
960 AMNESIA 5 0.0001
961 ANHEDONIA 2 0.0001
962 BLOOD GLUCOSE INCREASED 14 0.0001
963 DISTURBANCE IN ATTENTION 4 0.0001
964 INJURY 5 0.0001
965 SKIN BURNING SENSATION 5 0.0001
966 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
967 HOT FLUSH 5 0.0001
968 ILL-DEFINED DISORDER 4 0.0001
969 INFLUENZA 7 0.0001
970 MUSCULOSKELETAL STIFFNESS 5 0.0001
971 MOBILITY DECREASED 4 0.0001
972 ADVERSE DRUG REACTION 5 0.0001
973 BREAST CANCER 5 0.0001
974 PRODUCT SUBSTITUTION ISSUE 3 0.0001
975 SURGERY 3 0.0001
976 CATARACT 3 0.0001
977 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
978 DRUG INEFFECTIVE 61 0.0000
979 HOSPITALISATION 7 0.0000
980 PRODUCT QUALITY ISSUE 6 0.0000
981 SUICIDAL IDEATION 4 0.0000
982 CARDIAC DISORDER 4 0.0000
983 DEVICE MALFUNCTION 3 0.0000
984 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
985 OVERDOSE 9 0.0000
986 TREATMENT FAILURE 3 0.0000
987 RHEUMATOID ARTHRITIS 4 0.0000
988 ILLNESS 3 0.0000
989 NO ADVERSE EVENT 5 0.0000
990 INCORRECT DOSE ADMINISTERED 6 0.0000
991 ARTHRITIS 2 0.0000
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
993 PRODUCT DOSE OMISSION ISSUE 7 0.0000
994 ASTHMA 2 0.0000
995 INJECTION SITE PAIN 3 0.0000